Krisanee Pansue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Krisanee Pansue has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Juliet Ryan
MD Program, Weill Cornell Medical College, New York, NY, USA
1 shared publicationJuthamanee Moonwong
Center of Excellence for Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, Bangkok, Thailand
1 shared publicationKessarin Thanapirom
Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
1 shared publicationPathariya Promsena
Center of Excellence for Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, Bangkok, Thailand
1 shared publicationSurinda Kawichai
Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand
1 shared publicationThanyawee Puthanakit
Department of Pediatrics, Division of Infectious Disease, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
1 shared publication
Latest Publications
- 18 December 2024
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 36 (4) , 289-296
High prevalence of hepatitis C virus infection among adolescents and young adults attending HIV and sexual health clinics
Background: The prevalence of hepatitis C virus (HCV) infection among Thai adults is 0.5%–1.0%. This study aims to determine the prevalence of HCV infection among adolescents and young adults (AYA) accessing HIV/sexual health clinics. Methods: A cross-sectional study was conducted among AYA aged 15–24 years attending HIV/sexual health clinics in Bangkok, Thailand. The HCV infection prevalence, defined by anti-HCV antibody positivity using rapid diagnostic tests (SD BIOSENSOR, Korea), were reported with proportions and a 95% confidence interval (CI). Multivariate logistic regression was performed to identify factors associated with HCV infection. Results: From March to August 2023, 300 AYAs with a median age of 21 (interquartile range 20–23) years were enrolled into the study. One-third (29.7%) were people living with HIV (PLHIV). The overall prevalence of HCV infection was 2.7% (95%CI 1.2–5.2). Prevalence was higher among PLHIV (5.6%) compared to AYA without HIV (1.4%) ( p -value 0.053). The factor most significantly associated with HCV infection was people who used drugs (adjusted odds ratio 15.3, 95% CI 2.9–82.0, p -value 0.001). Conclusions: History of drug use was associated with the highest HCV infection prevalence. PLHIV had a trend of higher prevalence. HCV screening in HIV/sexual health clinics is recommended for early detection, treatment, and transmission reduction.
- 18 December 2024
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 36 (4) , 289-296
High prevalence of hepatitis C virus infection among adolescents and young adults attending HIV and sexual health clinics
Background: The prevalence of hepatitis C virus (HCV) infection among Thai adults is 0.5%–1.0%. This study aims to determine the prevalence of HCV infection among adolescents and young adults (AYA) accessing HIV/sexual health clinics. Methods: A cross-sectional study was conducted among AYA aged 15–24 years attending HIV/sexual health clinics in Bangkok, Thailand. The HCV infection prevalence, defined by anti-HCV antibody positivity using rapid diagnostic tests (SD BIOSENSOR, Korea), were reported with proportions and a 95% confidence interval (CI). Multivariate logistic regression was performed to identify factors associated with HCV infection. Results: From March to August 2023, 300 AYAs with a median age of 21 (interquartile range 20–23) years were enrolled into the study. One-third (29.7%) were people living with HIV (PLHIV). The overall prevalence of HCV infection was 2.7% (95%CI 1.2–5.2). Prevalence was higher among PLHIV (5.6%) compared to AYA without HIV (1.4%) ( p -value 0.053). The factor most significantly associated with HCV infection was people who used drugs (adjusted odds ratio 15.3, 95% CI 2.9–82.0, p -value 0.001). Conclusions: History of drug use was associated with the highest HCV infection prevalence. PLHIV had a trend of higher prevalence. HCV screening in HIV/sexual health clinics is recommended for early detection, treatment, and transmission reduction.